In Conversation

"Portugal is unique in Europe as it has electronic health records designed by the government in primary care and hospitals"

"[We provide] the fastest access to the best medical institutions and physicians at a competitive price"

"Historically, many British biotechnology companies have been acquired or sold their product(s) early in their existence. Immunocore will launch its first product in the ultra-rare disease…

While the UK may represent a relatively small percentage of overall global sales, our virtual impact is much bigger

"GSK Portugal wants to work in close collaboration with the authorities to maximize the number of patients treated with our innovative medicines and vaccines"

"Our new strategy focuses on expansion and entrance to the regulated markets of South America and Asia such as China, Korea, Japan, Brazil, Argentina and Chile"

"Spain is a natural place for us to be"

"I have always said that innovation is a marathon, not a sprint"

"Big data is the main opportunity that the healthcare sector can capitalize on in Spain, with this possibility increasing the productivity of the healthcare sector. The…

"Aside from the company’s success, Portugal is a fantastic pilot country. Despite the fact that we face many challenges, the way that we overcome these challenges…

"Otsuka has a smart strategy: it will never bring to market a ‘me too’ product. Aligned with our global mission of truly improving healthcare, we focus…

" We must work together in a collaborative spirit to shift the paradigm away from targeting purely low prices and instead, enhance the sustainability of the…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here